Geron arranges $50 million at-the-market offering of common stock

Company cancels prior at-the-market issuance sales agreement with MLV

By Angela McDaniels

Tacoma, Wash., Aug. 28 – Geron Corp. will sell up to $50 million of common stock through an at-the-market offering.

The agent, MLV & Co. LLC, will use commercially reasonable efforts to sell the stock from time to time and will receive a 3% commission, according to an 8-K filing with the Securities and Exchange Commission.

The offering will end on Aug. 28, 2018 or earlier if all the stock is sold.

The company and MLV terminated their at-the-market issuance sales agreement dated Oct. 8, 2012, which would otherwise have expired in October 2015. The company did not sell any stock under that agreement.

Geron is a clinical stage biopharmaceutical company based in Menlo Park, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.